-
公开(公告)号:CZ349698A3
公开(公告)日:1999-04-14
申请号:CZ349698
申请日:1997-04-25
Applicant: ABBOTT LAB
Inventor: ELLIOTT RICHARD L , OR YAT SUN , CHU DANIEL T , GRIESGRABER GEORGE W , PLATTNER JACOB J , PIREH DAISY
IPC: A61K31/04 , A61K31/70 , A61K31/7048 , A61K31/7052 , C07H17/08
Abstract: Novel 3-descladinose-2,3-anhydroerythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity selected from the group consisting of: (a) (I), (b) (II), (c) (III), and (d) (IV), pharmaceutical compositions comprising a therapeutically effective amount of a compound of formulas (I)-(IV) of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of formulas (I)-(IV) of the invention.
-
公开(公告)号:ZA9808642B
公开(公告)日:1999-03-31
申请号:ZA9808642
申请日:1998-09-21
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , C07F , A61K
CPC classification number: C07H17/08
-
63.
公开(公告)号:ZA988808B
公开(公告)日:1999-03-29
申请号:ZA988808
申请日:1998-09-25
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , MA ZHENKUN , CHU DANIEL T
IPC: A61K20060101 , C07D20060101 , C07F20060101 , C07D , A61K , C07F
-
公开(公告)号:AU9216298A
公开(公告)日:1999-03-29
申请号:AU9216298
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , CLARK RICHARD F , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula (I) (II), (III), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:AU8925398A
公开(公告)日:1999-03-22
申请号:AU8925398
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , LI LEPING , RUPP MICHAEL J , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61K31/7056 , A61P31/04 , C07H17/08 , C07H17/00
-
公开(公告)号:CA2301643A1
公开(公告)日:1999-03-18
申请号:CA2301643
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: CLARK RICHARD F , OR YAT SUN , CHU DANIEL T , PLATTNER JACOB J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having formula (I), (II), or (III), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:CA2301642A1
公开(公告)日:1999-03-11
申请号:CA2301642
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , LI LEPING , RUPP MICHAEL J , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61K31/7056 , A61P31/04 , C07H17/08 , C07H17/00
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula selected from the group consisting of (I), (II), (III), (IV) and (V), compositions comprising a therapeutically eff ective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically effective amount of a compound of formulas (I)-(V).
-
公开(公告)号:NO991022D0
公开(公告)日:1999-03-02
申请号:NO991022
申请日:1999-03-02
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , MA ZHENKUN , CLARK RICHARD F , CHU DANIEL T , PLATTNER JACOB J
Abstract: 6-Substituted ketolides of e.g. formula (II) or (III), and their salts, esters and prodrugs are new: Y + Z = X; X = OH, =NOR1 or =NOC(R5)(R6)OR1; or one of Y and Z = H; and the other = H, OH, protected OH or NR7R8; R1 = 1-12C alkyl (optionally substituted), 3-12C cycloalkyl or SiR2R3R4; R2-R4 = 1-12C alkyl or aryl; R5, R6 = H or 1-12C alkyl (optionally substituted), or R5 + R6 = 3-12C cycloalkyl; R7, R8 = H or 1-6C alkyl; or NR7R8 = 3-7 membered ring which, when the ring is 5-7 membered may optionally contain O, NH, N(1-6C alkyl), N(aryl), N(aryl-1-6C alkyl), N (substituted aryl-1-6C alkyl), N(heteroaryl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S or S(O)n; n = 1 or 2; Ra = H or OH; Rc = H or hydroxy protecting group; R9 = 1-6C alkyl (optionally substituted), 3-7C cycloalkyl or optionally substituted aryl or heteroaryl; M = CONH, NHCO, NH, N=, NMe, NHCOO, NHCONH, OCONHY, OCOO, O, S(O)n, COO, OCO or CO; R = methyl (substituted by CN, F, CO2R10, S(O)nR10, NHCOR10, NHCONR11R12, aryl, substituted aryl, heteroaryl or substituted heteroaryl); 2-10C alkyl (optionally substituted), 3C alkenyl (substituted by halo, CHO, CO2R10, COR9, CONR11R12, CN, optionally substituted aryl or heteroaryl, 3-7C cycloalkyl or 1-12C alkyl substituted by heteroaryl); 4-10C alkenyl (optionally substituted), or 3-10C alkynyl optionally substituted); R10 = 1-3C alkyl (optionally aryl substituted), or heteroaryl substituted 1-3C alkyl; R11, R12 = H or 1-3C alkyl (optionally substituted); A, B, D, E = H, 1-6C alkyl (optionally substituted by optionally substituted), 3-7C cycloalkyl, optionally substituted aryl or heteroaryl, heterocycloalkyl or 1-6C alkyl substituted by MR9; provided that \- 2 of A, B, D and E = H; or any one pair of substituents, consisting of AB, AD, AE, BD, BE or DE taken with the atoms to which they are attached, form a 3- to 7-membered ring optionally containing O, NH, N(1-6C alkyl), N(aryl-1-6C alkyl), N(substituted aryl-1-6C alkyl), N(heteroaryl-1-6C alkyl), N(substituted heteroaryl-1-6C alkyl), S, S(O)n, CONH, CONR12, NHCO, NR12CO or C(=NH)NH.
-
公开(公告)号:ZA9807689B
公开(公告)日:1999-02-24
申请号:ZA9807689
申请日:1998-08-25
Applicant: ABBOTT LAB
Inventor: OR YAT SUN , LI LEPING , RUPP MICHAEL J , CHU DANIEL T
IPC: A61K31/7042 , A61K31/7048 , A61K31/7056 , A61P31/04 , C07H17/08 , C07D , A61K , C07F
CPC classification number: C07H17/08
-
公开(公告)号:AU6271898A
公开(公告)日:1998-09-18
申请号:AU6271898
申请日:1998-02-06
Applicant: ABBOTT LAB
Inventor: WANG WEI-BO , KERDESKY FRANCIS A J , HSIAO CHI-NUNG W , LI QUN , CHU DANIEL T
IPC: C07D455/02
Abstract: A process for the preparation of a compound having the formula: wherein R1, R2, R3, R4, and R5 are defined, from an enamine by chain expansion and ring closure followed by additional derivatization, treatment with a 3-alkoxyl-acryloyl compound, another ring closure, and converting a hydroxyl group to a leaving group.
-
-
-
-
-
-
-
-
-